Novag Tuss (Dextromethorphan Hydrobromide)

Dextromethorphan Hydrobromide, the active ingredient in Novag Tuss, is an antitussive presented as an oral dosage form for oral use. It provides temporary relief of cough caused by minor throat and bronchial irritation in adults and children.

GNH USA supplies Novag Tuss as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novag Tuss contains dextromethorphan, an antitussive that acts on the cough centre of the medulla to suppress cough associated with minor airway irritation.

- Cough due to minor throat irritation: reduces frequency and intensity of coughing. - Cough due to mild bronchial irritation: provides temporary symptom relief. - Dry cough: helps suppress non‑productive cough episodes.

Novag Tuss may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Dizziness - Drowsiness or mild sedation - Nausea or upset stomach - Dry mouth - Constipation - Mild headache

Serious or Rare Side Effects: - Allergic reactions such as rash, itching or swelling - Serotonin syndrome when combined with serotonergic agents - Severe respiratory depression (rare, usually with overdose) - Hallucinations or psychotic symptoms - Severe skin reactions (e.g., Stevens‑Johnson syndrome) - Seizures (rare)

When using Novag Tuss, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Underlying respiratory disorders: use with caution in asthma or COPD. - Concurrent MAOI therapy: avoid co‑administration. - Alcohol consumption: limit intake as it may increase sedation. - Driving or operating machinery: may cause drowsiness; avoid if impaired. - Store at room temperature: keep in the original container, protect from moisture and heat.

Novag Tuss can interact with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome. - Other dextromethorphan‑containing cough products: risk of overdose. - Serotonergic agents (SSRIs, SNRIs, tramadol): increased serotonin toxicity.

Moderate Interactions (Monitor Closely):\n- CYP2D6 inhibitors (e.g., quinidine, fluoxetine): may raise dextromethorphan levels. - Central nervous system depressants (benzodiazepines, antihistamines): enhanced sedation. - Anticholinergic drugs: may exacerbate dry mouth and constipation.